|
American Cancer Society
and Centers for Disease Control and Prevention
Clinical Breast Exams:
Practical Recommendations for
Maximizing Performance and Reporting
Comments from the American College of
Preventive Medicine:
Thank you for the opportunity to
comment on the above document, which we find to be clearly
written, well organized, explicit, and useful with regard
to its intended goals. We do, however, have some concerns
that we believe could be addressed by the following
recommended general revisions:
- While the document does acknowledge a lack of
research regarding the effectiveness of CBE, there is
a consistent impression that CBE is indeed effective
and that the research to corroborate is just
insufficient to date. To conform to an evidence-based
approach, the paper should state explicitly that the
research needed to evaluate CBE could serve to
demonstrate its utility or its lack of utility.
Either way, standardization of methods is required so
that the research may proceed; heterogeneity in
performance decreases our ability to identify the true
utility of CBE.
- Throughout the document, biased statements (e.g.,
"…encouraging belief in the utility of CBE as
an independent, complementary component of good breast
health care;…" under training of trainers)
should be neutralized, or placed in an unbiased
context (e.g., trainers should encourage consistent
performance of standardized CBE as the necessary means
both to delivering a clinical service of acceptable
quality, and assuring a base of data amenable to
meaningful interpretation as the research effort to
elucidate the value of CBE advances…").
- We are concerned about statements throughout the
document that "CBE and mammography are
complementary examinations. Neither should be
substituted for the other," when systematic
reviews of the literature (such as those done for the
U.S. Preventive Services Task Force) have failed to
show an independent benefit of CBE. Thus, the USPSTF
recommends routine mammography with or without CBE at
this time. While is it logical and clinically prudent
to perform a CBE at the time of mammography,
compelling evidence that this increases screening
effectiveness is so far lacking.
- In our view, the standardization and training
recommended should be seen in the service of
facilitating research to establish the effectiveness
of CBE. Therefore, we recommend that research be
placed above training, standardization, and public
education as a priority in the recommendations, e.g.,
in the Executive Summary on pages 1-2.
- Athough we understand that Advisory Committee
discussions and a literature review gave fuller
attention to barriers, the elaboration in this
independent document fails to acknowledge that the
standardization of CBE methods advocated involves a
considerable time commitment on the part of the
practitioner and there is no discussion of prevailing
reimbursement policies. A reimbursement scheme for CBE
should be devised (or at least advocated) so that
until or unless it is no longer recommended, CBE can
be billed for commensurate with the time, effort, and
expertise on which it is based. Funds also should be
dedicated to an RCT to generate the data needed to
guide recommendations. Until or unless evidence
supports the effectiveness of CBE, use of the
examination will remain a matter of the individual
clinician’s discretion.
- Finally, we recommend shortening the final document
when it is circulated to clinicians.
In addition to the above general
comments, minor correction of typos are incorporated in
the attached version of the original document.
|